ASX Share rice
Sun 09 May 2021 - 05:56:pm (Sydney)

IXC Share Price

INVEX THERAPEUTICS LTDIXCPharmaceuticals, Biotechnology & Life Sciences

IXC Company Information

Name:

Invex Therapeutics Ltd

Sector:

Healthcare

Industry:

Biotechnology

Address:

38 Rowland Street Subiaco WA Australia 6008

Phone:

61 8 6382 0137

CFO & Company Sec.:

Ms. Narelle Warren B.Com., L.L.B., B.Com, LLB

Exec. Director & Chief Scientific Officer:

Prof. Alexandra Jean Sinclair

Company Overview:

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Subiaco, Australia.

IXC Share Price Information

Shares Issued:

75.15M

Market Capitalisation:

$51.10M

Revenue (TTM):

$165.70K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.03

Return On Assets (TTM):

$-0.10

Return On Equity (TTM):

$-0.19

Gross Profit(TTM):

$165.70K

Diluted Earnings Per Share (TTM):

$-0.05

IXC CashFlow Statement

CashFlow Date:

2020-06-30

Change To Liabilities:

$624.98K

Net Income:

$-3,360,279

Total Cash From Operating Activities:

$-1,603,393

Change To Account Receivables:

$36.49K

Sale Purchase Of Stock:

$16.25M

Capital Expenditures:

$0

IXC Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-3,360,280

Net Income:

$-3,360,280

Operating Income:

$-3,360,280

Total Revenue:

$165.70K

IXC Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$2.02M

Total Stockholder Equity:

$24.40M

Other Current Liabilities:

$1.30M

Total Assets:

$26.42M

Common Stock:

$27.02M

Retained Earnings:

$-3,592,401

Cash:

$26.30M

Total Current Liabilities:

$2.02M

Net Tangible Assets:

$24.40M

Total Current Assets:

$26.42M

Net Receivables:

$116.88K

Short-Term Investments:

$0

Accounts Payable:

$30.40K

Short-Term Investments:

$0

Non Current Liabilities Total:

$0

IXC Share Price History

IXC News

13 Feb, 2021
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
01 Sep, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...